Predictors For Transosseous Maxillary Sinus Lift Complications
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Baghdad
About this trial
This prospective cohort study aims to identify clinical and anatomical predictors for complications following transosseous maxillary sinus lift procedures using the Versah (Densah burs) technique. The study focuses on patients undergoing transcrestal sinus floor elevation without a lateral window, with or without simultaneous dental implant placement. Variables such as residual bone height, sinus membrane thickness, bone density, and patient-related factors are being evaluated. The objective is to enhance risk stratification and optimize treatment planning for transosseous sinus augmentation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
1- Patients requiring dental implants in the posterior maxilla with a residual bone height of < 6 mm.
Disqualifiers
1- Severe periodontal disease. 2- Residual bone height > 6 mm. 3- History of previous sinus lift procedures or other maxillofacial surgeries. 4- Smokers.
Trial design
Design model
Single group
Treatments tested in this trial
Transosseous Maxillary Sinus Lift using Osseodensification
Procedure/SurgeryA surgical procedure utilizing the Versah® osseodensification technique for transcrestal sinus floor elevation. The approach involves the use of specialized Densah® burs to prepare the osteotomy and elevate the sinus membrane through a transosseous (crestal) access, avoiding the lateral window technique. No grafting materials will be used in this procedure.
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Transosseous Sinus Lift GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Composite incidence of maxillary sinus membrane perforation and graft displacement, and identification of associated predictors
This primary outcome assesses the intraoperative occurrence of Schneiderian membrane perforation and graft displacement during transosseous maxillary sinus lift. It also involves the identification of anatomical and surgical predictors, including residual bone height (RBH), maxillary sinus ostium patency, sinus membrane thickness, surgical site, and the amount of vertical lift performed.
Time frame
Intraoperative phase to 1 month post-surgerySecondary outcomes
1
Postoperative Infection Rate
Incidence of infection or sinusitis following the transcrestal sinus lift procedure, confirmed clinically or radiographically.
Time frame
Within 3 months postoperativelySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov